In vitro activity of BRL 36650, a new penicillin.
AUTOR(ES)
Van Landuyt, H W
RESUMO
Compared with four beta-lactam antibiotics and amikacin, BRL 36650 and BMY-28142 were the most active against 509 Enterobacteriaceae, including cefotaxime-resistant isolates and resistant laboratory mutants. BRL 36650 was more active than aztreonam, ceftazidime, and BMY-28142 against Acinetobacter spp., Pseudomonas aeruginosa, and other Pseudomonas spp.; all strains were inhibited by 2 micrograms/ml or less.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=176413Documentos Relacionados
- In vitro activity of BRL 36650, a new semisynthetic penicillin.
- In vitro antibacterial properties of BRL 36650, a novel 6 alpha-substituted penicillin.
- Comparative in vitro study of temocillin (BRL 17421), a new penicillin.
- In vitro activity of temocillin (BRL 17421), a novel beta-lactamase-stable penicillin.
- BRL-36650: in vitro studies and assessment of serum bactericidal activity after single-dose administration in volunteers.
